These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6605118)

  • 21. HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis.
    Bardin T; Dryll A; Debeyre N; Ryckewaert A; Legrand L; Marcelli A; Dausset J
    Ann Rheum Dis; 1982 Dec; 41(6):599-601. PubMed ID: 6959574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
    N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penicillamine-associated myasthenia gravis.
    Albers JW; Hodach RJ; Kimmel DW; Treacy WL
    Neurology; 1980 Nov; 30(11):1246-9. PubMed ID: 6252512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)].
    Seitz D; Hopf HC; Janzen RW; Meyer W
    Dtsch Med Wochenschr; 1976 Jul; 101(31):1153-8. PubMed ID: 976101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis.
    Dawkins RL; Christiansen FT; Garlepp MJ
    Ann N Y Acad Sci; 1981; 377():372-84. PubMed ID: 6951482
    [No Abstract]   [Full Text] [Related]  

  • 26. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP; Rasker JJ; de Rooij DJ
    J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.
    Perrier P; Raffoux C; Thomas P; Tamisier JN; Busson M; Gaucher A; Streiff F
    Ann Rheum Dis; 1985 Sep; 44(9):621-4. PubMed ID: 3876081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis.
    Devogelaer JP; Isaac G; Noël H; De Bruyère M; Huaux JP; Nagant de Deuxchaisnes C
    Int J Clin Pharmacol Res; 1985; 5(3):143-7. PubMed ID: 4018948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
    Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
    Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA antigens in pencillamine-induced myasthenia gravis.
    Keesey J; Novom S
    Neurology; 1979 Apr; 29(4):528-9. PubMed ID: 571557
    [No Abstract]   [Full Text] [Related]  

  • 31. [D-penicillamine induced myasthenia gravis in a patient with rheumatoid arthritis].
    Kuriyama S; Hosoya T; Sakai O
    Ryumachi; 1991 Jun; 31(3):298-302; discussion 302-3. PubMed ID: 1948449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritis.
    Sweatman MC; Markwick JR; Charles PJ; Jones SE; Prior JM; Maini RN; Turner-Warwick ME
    Dis Markers; 1986 Jun; 4(1-2):19-26. PubMed ID: 3133152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-penicillamine-induced myasthenia gravis in rheumatoid arthritis.
    Froelich CJ; Hashimoto F; Searles RP; Bankhurst AD
    J Rheumatol; 1979; 6(2):237-9. PubMed ID: 458795
    [No Abstract]   [Full Text] [Related]  

  • 34. [Myasthenic syndrome following oral treatment with penicillamine].
    François J; Verbraeken H; Gabriel P; Wille C
    Bull Soc Belge Ophtalmol; 1978; 182():126-30. PubMed ID: 756327
    [No Abstract]   [Full Text] [Related]  

  • 35. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-penicillamine induced myasthenia gravis. Its relevance for the anaesthetist.
    Fried MJ; Protheroe DT
    Br J Anaesth; 1986 Oct; 58(10):1191-3. PubMed ID: 3768231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuromuscular complications of D-penicillamine in rheumatoid arthritis].
    Dubost JJ; Soubrier M; Bouchet F; Kemeny JL; Lhopitaux R; Bussière JL; Sauvezie B
    Rev Neurol (Paris); 1992; 148(3):207-11. PubMed ID: 1604135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The toxicity of D-penicillamine in systemic sclerosis.
    Steen VD; Blair S; Medsger TA
    Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HLA genomic tissue typing in myasthenic patients with rheumatoid arthritis].
    Varga E; Varga E; Jáger R; Petró A; Gyódi E; Bálint G; Náfrádi L; Varga L
    Orv Hetil; 2001 Oct; 142(41):2255-7. PubMed ID: 11760469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.